Preventive effects of a flavonoid myricitrin on the formation of azoxymethane-induced premalignant lesions in colons of rats

Asian Pacific Journal of Cancer Prevention

Volumn 8, Issue 1, 2007, Pages 73-76

  Asano, Nami ^a   Kuno, Toshiya ^b   Hirose, Yoshinobu ^a   Yamada, Yasuhiro ^a   Yoshida, Koujirou ^a   Tomita, Hiroyuki ^a   Nakamura, Yoshiyuki ^c   Mori, Hideki ^a  

^a GIFU UNIVERSITY   (Japan)

^b KAGAWA UNIVERSITY   (Japan)

^c SUGIYAMA JOGAKUEN UNIVERSITY   (Japan)

Author keywords

Aberrant crypt foci; Beta catenin accumulated crypts; Colon cancer; Myricitrin; Prevention

Indexed keywords

AZOXYMETHANE; BETA CATENIN; CARCINOGEN; FLAVONOID; MYRICETIN 3 RHAMNOSIDE; UNCLASSIFIED DRUG;

ANIMAL; ARTICLE; CELL TRANSFORMATION; CHEMICALLY INDUCED DISORDER; COLON TUMOR; DIET; DRUG EFFECT; FISCHER 344 RAT; MALE; PATHOLOGY; PRECANCER; RAT;

ANIMALS; AZOXYMETHANE; BETA CATENIN; CARCINOGENS; CELL TRANSFORMATION, NEOPLASTIC; COLONIC NEOPLASMS; DIET; FLAVONOIDS; MALE; PRECANCEROUS CONDITIONS; RATS; RATS, INBRED F344;

EID: 34547765959     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Ames BN (1983). Dietary carcinogens and anticarcinogens. Oxygen radicals and degenerative diseases. Science, 221, 1256-64.
2. Bird RP (1995). Role of aberrant crypt foci in understanding the pathogenesis of colon cancer. Cancer Lett, 93, 55-71.
3. Bird RP (1987). Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett, 37, 147-51.
4. Block G, Patterson B, Subar A (1992). Fruit, vegetables, and cancer prevention: a review of the epidemiological evidence. Nutr Cancer, 18, 1-29.
5. Boyle P, Zaridze DG, Smans M (1985). Descriptive epidemiology of colorectal cancer. Int J Cancer, 36, 9-18.
6. Corpet DE, Tache S (2002). Most effective colon cancer chemopreventive agents in rats: a systematic review of aberrant crypt foci and tumor data, ranked by potency. Nutr Cancer, 43, 1-21.
7. Edenharder R, Grunhage D (2003). Free radical scavenging abilities of flavonoids as mechanism of protection against mutagenicity induced by tert-butyl hydroperoxide or cumene hydroperoxide in Salmonella typhimurium TA102. Mutat Res, 540, 1-18.
8. Hebert JR, Landon J, Miller DR (1993). Consumption of meat and fruit in relation to oral and esophageal cancer: a crossnational study. Nutr Cancer, 19, 169-79.
9. Henderson BE, Ross RK, Pike MC (1991). Toward the primary prevention of cancer. Science, 22, 1131-8.
10. Hirose Y, Kuno T, Sheng HQ, et al. (2005). Beta-cateninaccumulated crypts (BCAC) or aberrant crypt foci (ACF): which biomarker is more reliable? In "Carcinogenesis and modification of carcinogenesis" Eds Tanaka T and Tsuda H. Research Signpost, Kerala, pp 129-34.
11. Hirose Y, Kuno T, Yamada Y, et al. (2003). Azoxymethane-induced beta-catenin-accumulated crypts in colonic mucosa of rodents as an intermediate biomarker for colon carcinogenesis. Carcinogenesis, 24, 107-11.
12. Iio M, Himeno S, Miyauchi K, et al. (1983). Effect of flavonoids on gloxalase I Activity. Nippon Nogeikagaku Kaishi (Japanese), 57, 765-9.
13. Ju J, Hong J, Zhou JN, et al. (2005). Inhibition of intestinal tumorigenesis in Apcmin/+ mice by (-)-epigallocatechin-3-gallate, the major catechin in green tea. Cancer Res, 65, 10623-31.
14. Kelloff GJ, Boone CW, Crowell JA, et al. (1994). Chemopreventive drug development: perspectives and progress. Cancer Epidemiol Biomarkers Prev, 3, 85-98.
15. Kleijnen J, Knipschild P (1992). Ginkgo biloba. Lancet, 34, 1136-9.
16. Kuntz S, Wenzel U, Daniel H (1999). Comparative analysis of the effects of flavonoids on proliferation, cytotoxicity, and apoptosis in human colon cancer cell lines. Eur J Nutr, 38, 133-42.
17. Landis SH, Murray T, Bolden S, et al. (1999). Cancer Statistics. CA Cancer J Clin, 49, 8-31.
18. Luo XD, Basile MJ, Kennelly EJ (2002). Polyphenolic antioxidants from the fruits of Chrysophyllum cainito L. (Star Apple). J Agric Food Chem, 50, 1379-82.
19. McGregor D (1998). Diets, food components and human cancer. Biotherapy, 11, 189-200.
20. Mori H, Yamada Y, Kuno T, et al. (2004). Aberrant crypt foci and beta-catenin accumulated crypts; significance and roles for colorectal carcinogenesis. Mutat Res, 566, 191-208.
21. Nomoto H, Iigo M, Hamada H, et al. (2004). Chemoprevention of colorectal cancer by grape seed proanthocyanidin is accompanied by a decrease in proliferation and increase in apoptosis. Nutr Cancer, 49, 81-8.
22. Pretlow TP, Barrow BJ, Ashton WS, et al.. (1991). Aberrant crypts: putative preneoplastic foci in human colonic mucosa. Cancer Res, 51, 1564-7.
23. Robak J, Gryglewski RJ (1988). Flavonoids are scavengers of superoxide anions. Biochem Pharmacol, 37, 837-41.
24. Suzuki R, Kohno H, Murakami A, et al.. (2004). Citrus nobiletin inhibits azoxymethane-induced large bowel carcinogenesis in rats. Biofactors, 22, 111-4.
25. Stavric B (1994). Role of chemopreventers in human diet. Clin Biochem, 27, 319-32.
26. Tsuruo T, Naito M, Tomida A, et al.. (2003). Molecular targeting therapy of cancer: drug resistance, apoptosis and survival signal. Cancer Sci, 94, 15-21.
27. Weisburger JH (1991). Nutrition approach to cancer prevention with emphasis on vitamin, antioxidants and carotenoids. Am J Clin Nutr, 53, 226s-37s.
28. Willett W (1989). The search for the causes of breast and colon cancer. Nature, 338, 389-94.
29. Yamada Y, Yoshimi N, Hirose Y, et al. (2001). Sequential analysis of morphological and biological properties of beta-cateninaccumulated crypts, provable premalignant lesions independent of aberrant crypt foci in rat colon carcinogenesis. Cancer Res, 61, 1874-8.
30. Yamada Y, Yoshimi N, Hirose Y, et al.. (2000). Frequent betacatenin gene mutations and accumulations of the protein in the putative preneoplastic lesions lacking macroscopic aberrant crypt foci appearance, in rat colon carcinogenesis. Cancer Res, 60, 3323-7.
31. Yokomizo A, Moriwaki M (2005a). Transepithelial permeability of myricitrin and its degradation by simulated digestion in human intestinal caco-2 cell monolayer. Biosci Biotechnol Biochem, 69, 1774-6.
32. Yokomizo A, Moriwaki M (2005b). Myricitrin degraded by simulated digestion inhibits oxidation of human low-density lipoprotein. Biosci Biotechnol Biochem, 69, 693-9.
33. Zhong X, Otsuka H, Ide T, et al.. (1997). Three flavonol glycosides from leaves of Myrsine seguinii. Phytochemistry, 46, 943-6.